DVC1-0401

N/A

Report date: 2023/06/29 15:01:46

Base Information

Drug NameDVC1-0401

Drug Alias NameDVC1-0401

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vectorCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector > SIV vector

Mechanisms of ActionPigment epithelium-derived factor modulatorsGene transference

TargetsPigment epithelium-derived factor

Therapy Area/IndicationsRetinitis Pigmentosa

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesId Pharma Kyushu University

China Registration ClassN/A

Develop Information

Active CompaniesId Pharma Kyushu University

Inactive CompaniesN/A

Active IndicationsRetinitis Pigmentosa

Inactive IndicationsN/A

Other Information

ATC CodeN/A